EATG » Hepatitis

Hepatitis

When to use direct-acting antivirals in hepatocellular carcinoma

During the last several decades, the incidence of hepatocellular carcinoma (HCC) has risen sharply in the United States and globally, driven partly by an increase in hepatitis C virus (HCV)…

Glecaprevir/pibrentasvir is efficacious for treatment of HCV in highly endemic areas

According to study results published in Liver International, glecaprevir/pibrentasvir (GLE/PIB) is efficacious for the treatment of hepatitis C virus (HCV) in highly endemic areas.1 GLE/PIB is a recently approved pan-genotypic regimen that has…

VCTE superior marker for measuring fibrosis in patients with HBV/HIV

Vibration-controlled transient elastography outperformed aspartate aminotransferase to platelet ratio index and Fibrosis-4 index as a noninvasive biomarker for advanced fibrosis in patients with hepatitis B and HIV coinfection, according to a study…

US: Less than 30% of high-risk adults protected from HBV

National survey data showed that, as of 2014, less than one in three U.S. adults at high risk for hepatitis B infection were protected against the virus, according to a…

Expert panel advises catch-up hep A vaccination

CDC experts recommend the vaccine for children, teens and HIV-positive people. On June 27, the Advisory Committee on Immunization Practices (ACIP), part of the Centers for Disease Control and Prevention…

Hepatitis C treatment in primary care delivers higher cure rate for people who inject drugs

Providing treatment for hepatitis C in the primary care setting significantly improves the uptake of treatment and cure rates in people who inject drugs, a randomised study conducted in Australia…

HBV vaccine response in adults with HIV and coinfection prevention

Hepatitis B virus (HBV) vaccine response is good in individuals with HIV and therefore should be given to aid in prevention of HBV, to reduce costs of treatment, and to help…

Gaps in Viral Hepatitis Awareness in the United States

According to a new study published in Clinical Gastroenterology and Hepatology, less than half of adults who are infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) in the United States are aware…

The burden of viral hepatitis in the WHO Region of Africa

Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the…

Scaling-Up Prevention and Treatment Interventions for Achieving HCV Elimination

A modest scale-up of hepatitis C virus (HCV) treatment, along with medication-assisted treatment and syringe service programs where needed, can reverse the expanding HCV burden in the United States and reach elimination…